Korea Advanced Institute of Science and Technology
发明人:
申请号：
EP16855780.9
公开号：
EP3363464A1
申请日:
2016.10.14
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present disclosure provides a pharmaceutical composition for treating cancer comprising an RNA oligonucleotide having a particular sequence and structure. Specifically, when a cell line is treated with an RNA oligonucleotide having specific sequence and helical bend structure according to the present disclosure, the expression of ISG56 is increased and apoptosis of cancer cells is induced. Thus, a composition comprising the RNA oligonucleotide can be used as an anticancer agent.
